Dr. Ioana R. Bonta, MD

Dr. Bonta practices at Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital.

Dr. Bonta's NPI, 1306090659, was assigned on November 13, 2008. Dr. Bonta holds Georgia license 63295.

Dr. Bonta's primary practice is Northside Hospital Atlanta, at 1000 Johnson Ferry Road, NE, Atlanta, GA 30342 in Fulton County. The practice phone is (404) 851-8000.

Dr. Bonta's primary practice is Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital. Dr. Bonta is also affiliated with Emory University Hospital Midtown. The medical group on file is City of Hope Atlanta. Dmand AI also links Dr. Bonta to 3 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bonta practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bonta's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Bonta's licenses on file in 2 states: Georgia and Illinois.

CMS data shows 666 Medicare services from Dr. Bonta across 10 procedure codes in 2024, for 194 Medicare patients. Medicare paid $34,782 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 194 Medicare patients who saw Dr. Bonta in 2024. The largest group is 75 to 84, with 84 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bonta's median patient age at 68, with 58% women.

In 2024, Dr. Bonta wrote 603 Medicare Part D claims for 110 patients. 74% of them were for generic drugs. CMS names the drug for 271 of them, across 17 drugs with 11 or more claims each, at $494,404 in total drug cost. In 2023, CMS named 310 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Bonta for performance year 2024, reported as part of a group. Dr. Bonta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bonta as offering telehealth.

Dmand AI links 4 papers to Dr. Bonta, published from 2017 to 2024. The most frequent topics are Protein Kinase Inhibitors. Dr. Bonta has published most often in J Thorac Oncol. Dr. Bonta's most frequent co-authors are Anjali Anil Bharne, MD, Thangavijayan Bosemani, MD and Dan Costin, MD.

Dmand AI links Dr. Bonta to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Thyroid Cancer, Papillary and Adenocarcinoma, Papillary.

CMS Open Payments shows 601 general payments to Dr. Bonta from 62 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. Janssen Pharmaceuticals, Inc paid the most, $22,291.